Source: International Congress 2019 – Hot topics in pulmonary rehabilitation
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Jarosch (Marburg, Germany), T. Schneeberger (Marburg, Germany), R. Gloeckl (Munich, Germany), D. Leitl (Marburg, Germany), C. Schneider (Marburg, Germany), R. Koczulla (Marburg, Germany), K. Kenn (Marburg, Germany). Short-term effects of supplemental oxygen during exercise in patients with idiopathic pulmonary fibrosis (IPF). 3406

Member's Comments

No comment yet.

Related content which might interest you: Effects of oxygen inhalation during exercise in patients with combined pulmonary fibrosis and emphysema (CPFE) Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing Year: 2010 Are there differences in response to pulmonary rehabilitation (PR) in idiopathic pulmonary fibrosis (IPF) and COPD patients? Source: International Congress 2017 – New insights into pulmonary rehabilitation in patients with chronic lung diseases Year: 2017 The long-term safety of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Effect of metformin on clinically relevant outcomes in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 Exercise-induced pulmonary hypertension in patients with idiopathic pulmonary fibrosis: effects of oxygen Source: Eur Respir J 2007; 30: Suppl. 51, 607s Year: 2007 Protocol for long-term effect of pulmonary rehabilitation under nintedanib in idiopathic pulmonary fibrosis Source: ERJ Open Res, 7 (3) 00321-2021; 10.1183/23120541.00321-2021 Year: 2021 Patterns of discontinuation in the long-term RECAP study of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): treatment highlights Year: 2017 Effects of short-term pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 628s Year: 2006 Time-course changes in pulmonary haemodynamics in patients with idiopathic pulmonary fibrosis (IPF) waiting for lung transplantation (LT) Source: Eur Respir J 2004; 24: Suppl. 48, 668s Year: 2004 Benefit of treatment with pirfenidone (PFD) persists over time in patients with idiopathic pulmonary fibrosis (IPF) with limited lung function impairment Source: International Congress 2016 – IPF treatment I Year: 2016 Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis (IPF) with inspiratory muscle training Source: Annual Congress 2007 - Assessment and outcomes in non-COPD patients Year: 2007 Determinants of exercise limitation in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 107s Year: 2005 Impact of oxygen supplementation on inflammatory response and muscle lesion during high intensity exercise on chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2006 - Muscles, training and rehabilitation Year: 2006 Effects of oral dual ERA therapy on pulmonary function testing and 6MWT in patients with idiopathic pulmonary fibrosis and pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH Year: 2012 Abnormal pulmonary arterial remodelling in patients with combined pulmonary fibrosis emphysema (CPFE) and idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2011 - Clinical approach of diffuse parenchymal lung disease Year: 2011 Effect of continued pirfenidone treatment following a ≥ 15% decline in 6-minute walk distance (6MWD) in patients with idiopathic pulmonary fibrosis (IPF): Pooled analysis from 3 pivotal studies Source: International Congress 2016 – New and old therapies for chronic lung diseases Year: 2016 Exercise capacity in idiopathic pulmonary fibrosis and COPD Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010 Benefits of supplemental oxygen on exercise capacity in IPF patients without exercise-induced hypoxemia Source: International Congress 2019 – Oxygen supplementation, noninvasive ventilation and mobility aspects of patients with impaired respiration Year: 2019 Changes in biomarkers in patients with idiopathic pulmonary fibrosis (IPF) treated with nintedanib and sildenafil Source: International Congress 2019 – The evolving field of idiopathic interstitial pneumonia Year: 2019 Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis Source: Eur Respir J 2012; 39: 359-365 Year: 2012